A New Immune-Biochemical Study To Identify Indicators Of The Response Of Infertile Polycystic Ovary Syndrome Patients To Metformin Treatment

June 2025 in “ International Journal of Environmental Sciences ”

Sura O. Yousif, Rasha Hasan Jasim

polycystic ovary syndrome PCOS Metformin integrin CLEC10A interleukin-42

Studysummary In this study, researchers found that serum levels of integrin, CLEC10A, and interleukin-42 significantly differed between PCOS patients treated with infertility drugs and untreated PCOS patients when compared to healthy controls, suggesting these biomarkers could help differentiate treatment status in PCOS.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

This study investigated immune-biochemical indicators in 90 women with PCOS, divided into three groups: those treated for infertility, untreated PCOS patients, and a healthy control group. Using the Sandwich-ELISA technique, significant differences in integrin, CLEC10A, and interleukin-42 levels were found between the groups. Notably, CLEC10A and interleukin-42 levels were elevated in untreated PCOS patients compared to those treated with Metformin. Strong correlations were observed between these markers, with Metformin treatment showing a negative correlation between integrin and interleukin-42, and CLEC10A and interleukin-42. The study concluded that CLEC10A and interleukin-42 are effective in differentiating between Metformin-treated and untreated PCOS patients, with high sensitivity and specificity, suggesting their potential as diagnostic tools.

View this study on theaspd.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women

37 citations , October 2024 in “JAMA Network Open”

This study found that among reproductive-age women across India, there was a high prevalence of PCOS, with phenotype C being predominant and most women exhibiting metabolic abnormalities, highlighting the importance of integrating PCOS management into national health strategies.

research Evaluating the Diagnostic Accuracy of Androgen Measurement in Polycystic Ovary Syndrome: A Systematic Review and Diagnostic Meta-Analysis to Inform Evidence-Based Guidelines

22 citations , September 2024 in “Human Reproduction Update”

This study found that total testosterone and free testosterone are recommended as first-line tests for diagnosing biochemical hyperandrogenism in women with PCOS; liquid chromatography with tandem mass spectrometry is preferred for its accuracy.

research Targeting Integrin Pathways: Mechanisms and Advances in Therapy

54 citations , January 2023 in “Signal Transduction and Targeted Therapy”

This review examines integrins as pharmacological targets, discussing current integrin-based therapies and emphasizing the need to understand integrin mechanisms for successful drug development, without reporting new clinical results.